Mejora la respuesta incretina de forma sostenida
Saxenda (liraglutide) injection 3 mg is an injectable prescription medicine used for adults with obesity or overweight (excess weight) who also have weight-related medical problems, and children aged 12-17 years with a body weight above 132 pounds (60 kg) and obesity to help them lose weight and keep the weight off
AHI reduction: Tirzepatide 15mg reduced apnea-hypopnea events by approximately 25-30 per hour vs 5 per hour for placebo Responder rate: Around 42% of tirzepatide participants achieved complete or near-complete resolution of sleep apnea events Weight loss: Average 18% body weight reduction accompanied the AHI improvements, consistent with SURMOUNT-1 data at comparable doses Source: Malhotra et al., NEJM 2024 Sleep Apnea Dosing vs Weight Loss Dosing The titration schedule is the same for both indications
Immune Enhancement: Strengthens immune defenses for greater resilience
Monthly costs for the GLP-1s often exceed $1K per patient , driving up pharmacy spending across the board
Those types of claims may be valued at $50,000 to $150,000, depending on the duration and impact of the condition